These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 16621111

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ, Prigeon RL, D'Alessio DA.
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [Abstract] [Full Text] [Related]

  • 4. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
    Rickels MR, Mueller R, Markmann JF, Naji A.
    J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
    [Abstract] [Full Text] [Related]

  • 5. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
    Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M.
    Eur J Clin Invest; 2000 May; 30(5):411-8. PubMed ID: 10809901
    [Abstract] [Full Text] [Related]

  • 6. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [Abstract] [Full Text] [Related]

  • 7. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M, Ahrén B.
    Horm Metab Res; 2004 Jun; 36(11-12):795-803. PubMed ID: 15655711
    [Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.
    Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Elahi D.
    J Gerontol A Biol Sci Med Sci; 2001 Nov; 56(11):M681-5. PubMed ID: 11682575
    [Abstract] [Full Text] [Related]

  • 9. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH, Pilgaard K, Vilsbøll T, Jensen CB, Deacon CF, Holst JJ, Vølund A, Madsbad S, Vaag AA.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
    [Abstract] [Full Text] [Related]

  • 12. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus.
    Luzi L, Hering BJ, Socci C, Raptis G, Battezzati A, Terruzzi I, Falqui L, Brandhorst H, Brandhorst D, Regalia E, Brambilla E, Secchi A, Perseghin G, Maffi P, Bianchi E, Mazzaferro V, Gennari L, Di Carlo V, Federlin K, Pozza G, Bretzel RG.
    J Clin Invest; 1996 Jun 01; 97(11):2611-8. PubMed ID: 8647955
    [Abstract] [Full Text] [Related]

  • 13. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion.
    Kizilel S, Scavone A, Liu X, Nothias JM, Ostrega D, Witkowski P, Millis M.
    Tissue Eng Part A; 2010 Jul 01; 16(7):2217-28. PubMed ID: 20163204
    [Abstract] [Full Text] [Related]

  • 14. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS, Aponte GW.
    Am J Physiol; 1995 Dec 01; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [Abstract] [Full Text] [Related]

  • 15. In vivo treatment with glucagon-like peptide 1 promotes the graft function of fetal islet-like cell clusters in transplanted mice.
    Suen PM, Li K, Chan JC, Leung PS.
    Int J Biochem Cell Biol; 2006 Dec 01; 38(5-6):951-60. PubMed ID: 16172015
    [Abstract] [Full Text] [Related]

  • 16. Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
    Luo J, Nguyen K, Chen M, Tran T, Hao J, Tian B, Rulifson IC, Zhang Y, Tian L, Zhang Y, Lopez E, Lin DC, Wang Y, Ma Z, Houze J, Guo Z.
    Metabolism; 2013 Jan 01; 62(1):90-9. PubMed ID: 22982177
    [Abstract] [Full Text] [Related]

  • 17. Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes.
    Rickels MR, Schutta MH, Mueller R, Markmann JF, Barker CF, Naji A, Teff KL.
    Diabetes; 2005 Nov 01; 54(11):3205-11. PubMed ID: 16249446
    [Abstract] [Full Text] [Related]

  • 18. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
    Salehi M, Vahl TP, D'Alessio DA.
    J Clin Endocrinol Metab; 2008 Dec 01; 93(12):4909-16. PubMed ID: 18827000
    [Abstract] [Full Text] [Related]

  • 19. Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.
    Prigeon RL, Quddusi S, Paty B, D'Alessio DA.
    Am J Physiol Endocrinol Metab; 2003 Oct 01; 285(4):E701-7. PubMed ID: 12773303
    [Abstract] [Full Text] [Related]

  • 20. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC, Lavery KS, Irwin N, Green BD, Greer B, Harriott P, O'Harte FP, Gault VA, Flatt PR.
    J Endocrinol; 2006 Oct 01; 191(1):93-100. PubMed ID: 17065392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.